Baseline haematological and biochemical reference values for healthy male adults from Mali by Vita, Serena et al.
1 
 
BASELINE HAEMATOLOGICAL AND BIOCHEMICAL REFERENCE VALUES FOR 
HEALTHY MALE ADULTS FROM MALI 
 
 
Vita Serena
1-2
, Miglietta Alessandro
2
, Lopalco Maurizio
3
, Terrazzini Nadia
4
, Sargentini 
Valeria
5
,
 
Cella Eleonora
6
, Bachetoni Alessandra
5
, Dicuonzo Giordano
7
, Angeletti Silvia
4
, 
Ciccozzi Massimo
6
 and Ceccarelli Giancarlo
1-2
 
On behalf of Sanitary Bureau of Asylum Seekers Center of Castelnuovo di Porto (Cuomo 
MR, Di Bari V, Fontanelli Sulekova L, Gangarossa G, Keh Buma Dinga C, Balint M, Conti 
Papuzza I, Dimitrova E, Di Renzo V, Leonardi M, Velez-Cervantes L, Walter I). 
1
Migrant Health Research Organisation (Mi-HeRO) - Centro di Ricerca sulla Salute delle 
Popolazioni Mobili e Globale, Italy; Department of Public Health and Infectious Diseases, 
Sapienza University of Rome, Policlinico Umberto I, Rome, Italy. 
2
Units of Epidemiology and Preventive Medicine, Central Tuscany Health Authority, 
Florence, Italy.  
3
Sanitary Bureau of Asylum Seekers Center of Castelnuovo di Porto, Rome, Italy; Auxilium 
Società Cooperativa Sociale, Senise (PZ), Italy. 
4
School of Pharmacy and Biomolecular Sciences, University of Brighton, United Kingdom. 
5
Clinical Pathology, Department of Experimental Medicine, Sapienza University of Rome, 
Italy. 
6
Unit of Medical Statistics and Molecular Epidemiology, University Campus Bio-Medico of 
Rome, Italy 
 
2 
 
7
Clinical Pathology and Microbiology Laboratory, University Hospital Campus Bio-Medico 
of Rome, Italy. 
8
 Unit of Clinical Laboratory Science, University Campus Bio-Medico of Rome, Italy 
 
 
*Correspondence to: Serena Vita, MD PhD, Migrant Health Research Organisation (Mi-
HeRO) - Centro di Ricerca sulla Salute delle Popolazioni Mobili e Globale, Italy, Via del 
Pigneto 3 00176 Rome, Italy; e-mail: serena.vita@mihero.org 
3 
 
 
ABSTRACT  
Background: Haematological reference values are very important for diagnostic orientation 
and treatment decision. The aim of this study was to establish haematological reference 
values for Malian healthy adults. 
Methods: A cross-sectional study including 161 male Malians  aged between 19 and 54 years 
old was performed. Median and reference ranges were calculated for haematological and 
biochemical parameters. Parametric student’s t-test was used to determine any statistically 
significant differences by age, smoker status, body mass index (BMI) and occupation. Ranges 
were further compared with those reported for other African , Afro-American and Caucasian 
populations.  
Results: Increased levels of MCV, MCH, PLT and EOS were found in younger Malians who 
had abnormal BMI and altered platelets parameters . Notably, significantly lower eosinophil 
and monocyte counts were observed in Malians compared to  Europeans The smoking status 
did not seem to directly affect RIs.  
Conclusions: This is the first study to determine normal laboratory parameters in Malian 
adult males. Our results underscore the necessity of establishing region-specific clinical 
reference ranges that would allow clinicians and practitioners to manage laboratory tests, 
diagnosis and therapies. These data are useful not only for the management of patients in 
Mali, but also to support European and American clinicians in the health management of 
asylum seekers and migrants from Mali. 
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INTRODUCTION 
Since 2012, Mali has been in the grip of an unprecedented political crisis, causing a constant 
and numerically significant migration to Southern Europe. As a consequence of the increase 
in migration flows, the need for access to diagnostic tests and medical evaluations by Malians 
is steadily growing in host countries. Therefore, general practitioners and clinicians need 
more information on the health status of asylum applicants, for diagnosis orientation and 
treatment decisions. 
Reference intervals (RIs) of haematologic indices have not yet been established in Mali and 
in most African countries. RIs have an important role in clinical practice and are used in  
disease screening as well in assessing disease progression and treatment response. The use of 
accurate RIs can reduce the risk of disease misdiagnosis, allows an early diagnosis and 
improves patient care. Guidelines by the International Federation of Clinical Chemistry 
(IFCC) recommend that every country establish RIs of healthy adult populations [1]. 
Common practice in African countries is to use laboratory reference values derived from data 
collected from populations living in industrialized countries [2]. Discrepancies between  
normal reference values  in industrialized  and  African  countries have been reported in the 
literature [3,4], possibly due to factors such as age, sex, and geographic origin of different 
ethnic groups [5,6].  
The main aim of our study was to determine RIs of hematological and clinical chemistry 
parameters in healthy male adults coming from Mali, recruited at the Asylum Seekers Center 
(ASC) in Castelnuovo di Porto, Italy.  The secondary objective was to evaluate the impact of 
anthropometric, behavioral, social and metabolic variables on haematological and 
biochemical analyses. 
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METHODS 
This cross-sectional retrospective study was conducted on data  from  blood tests collected 
from adult Malians, within 3 months of their arrival in Italy, at the Internal Healthcare 
Facility (IHCF) of the ASC of Castelnuovo di Porto (Rome, Italy), between May and 
November 2014.  
In accordance with  internal procedures, each Asylum Seeker (AS) who accessed  the IHCF 
for the first time was interviewed using a standardized questionnaire focused on socio-
demographic data and medical history. Medical staff conducted interviews with the support 
of mediators speaking the patient’s mother tongue. Moreover, a physical examination, 
including the collection of vital signs and anthropometric data, was performed. 
The study was carried out in accordance with the Helsinki Declaration and data were 
collected and analyzed after receiving informed consent. Ethical approval was not required 
because the study was based on a retrospective analysis of data routinely collected and stored 
according to the Italian law on privacy (General authorization to process personal data for 
scientific research purposes granted by the Italian Data Protection Authority (1 March 2012 
as published in Italy’s Official Journal no. 72 dated 26 March 2012)). 
 
Reference Range Analysis 
Haematological and chemistry laboratory tests included: erythrocytes (RBC), haemoglobin 
concentration (Hb), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular 
hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red blood cell 
distribution width (RDW), concentrations of leukocytes (WBC), lymphocytes (LYM), 
neutrophils (NEUT), monocytes (MON), eosinophils (EOS) and basophiles (BAS), absolute 
number and the percentages (%) of LYM/NEUT/MON/EOS or BAS, platelets (PLT), platelet 
distribution width (PDW), mean platelet volume (MPV), and plateletcrit (PCT), creatinine, 
azotemia, glucose, aspartate aminotransferase (AST), alanine aminotransferase (ALT). 
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Partecipantswere also tested for HbsAg, and for antibodies against HIV and HCV . 
 
Blood Collection and Testing Methodologies 
Routine blood tests for hematology, blood chemistry, and virologic assessment were offered 
to all adults examined. 
For hematology, the blood was collected in a Becton Dickinson (BD) ethylene diamine tetra-
acetic acid (EDTA) Vacutainer tube (Franklin Lakes, NJ, USA), while for biochemistry tests 
the blood was collected in a BD serum separation tube (SST) that was centrifuged (3,000 g, 3 
minutes). All samples were analysed within 3 hours of collection. 
Blood samples were analysed using Sysmex XN 1000 automated hematology analyzer for 
complete blood counts, as recommended by the manufacturer. Dimension Vista 1500 
Intelligent Lab System (Siemens) was used to analyze serum biochemical parameters.  
Hepatitis B virus surface antigen (HBsAg), hepatitis C virus antibody (HCV-Ab) and human 
immunodeficiency virus antibody (HIV-Ab) were detected by a third-generation enzyme 
linked immunoassay (Abbott). 
  
Statistical Methods 
For each of the clinical, biochemical and haematological parameters of the study , reference 
values were determined at 2.5
th
-97.5
th 
percentiles; mean, median and standard deviations 
(±SD) were also computed. Parametric student’s t-test was used to determine any statistically 
significant differences between the age groups ≤25 and ≥26, smokers and no smokers, normal 
and abnormal Body Mass Index (BMI). BMI was considered abnormal if > 25 or < 18.5 
according to World Health Organization (ref http://www.euro.who.int/en/health-
topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi) In order to test 
for differences in the parameters in relation to the occupation (i.e. craftsman, farmer, 
student/unemployed, trader), one-way ANOVA with post-hoc analysis using the Scheffe test 
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were conducted. Analyses were carried out using Stata 10.1 software; p<0.05 values were 
considered statistically significant. 
 
RESULTS 
Study population 
Out of 161 Malian males who had haematological and biochemical  tests, 36 were excluded 
from the analysis due to factors that made them ineligible for study participation and could 
have affected their suitability for reference values. Of the 36 excluded, 25 (69.4%) were 
positives for HBsAg, 2 (5.6%) were anti-HCV positives and 1 (2.7%) was double positive for 
HBsAg and anti-HCV. Moreover, 8 (22.3%) partecipants were excluded because their 
analyses were performed 4 months after their arrival to the reception center. This left a total 
sample of 125 healthy participants from whom the reference ranges were calculated. 
Participants’ median age was 25, ranging from 19 to 54 years-old (SD±6). Information on 
weight and height was available for 105 Malians. Most of them (n=83; 79.04%) had a normal 
BMI (18.75 - 24.78), 4 (3.80%) were underweight or in the mild thinness Class (i.e. BMI 
range: 17.28 - 18.08), 13 (12.38%) were overweight (i.e. BMI range: 25.06 - 29.73) and 2 
(1.90%) had an obesity class I (i.e. BMI 30.25 and 30.64 respectively). Thirty one 
participants (24.8%) stated to be smokers. More than half of the partecipants enrolled had no 
education (n=74; 63.79%). The principal occupation was farmer (n=36; 31.3%), followed by 
craftsman (n=29; 25.22%). 
 
Clinical, haematological and biochemical parameters 
The median reference values (2.5
th
-97.5
th
 percentiles), mean and ±SD for clinical, 
haematological and biochemical parameters collected from all participants enrolled in the 
study are shown in Table 1. 
Data presented are calibrated on Malian healthy adult males, unweighted for anthropometric 
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parameters and social factors. 
 
 
Impact of anthropometric and social factors on clinical and laboratory parameters 
Samples were further stratified by age, BMI, smoker status and type of employment.  
The population was classified in 2 groups by age, young adults ≤25 years old and adults ≥26 
years old, taking into account the median age (25 years). MCV/MCH/MON % and creatinine 
were statistically significantly higher in adults group (MCV p-value=0.01; MCH p-
value=0.01; MON% p-value=0.02, creatinine p-value=0.01; data not shown), while PLT10^3 
and EOS% were significantly higher in the young adults group (PLT10^3 p-value=0.01; 
EOS% p-value<0.01; additional file 1). 
MPV, PCT, PDW and ALT were statistically significantly higher in the abnormal BMI group 
(MPV p-value=0.02; PCT p-value=0.02; PDW p-value=0.02; ALT p-value = 0.03; additional 
file 1). 
No statistically significant differences were found between smoking and no-smoking groups 
(additional file 1) although HB, HCT and PLT 10^3 were at the limits of statistical 
significance (p=0.05). HB and HCT tended to be higher in no-smokers than in smokers, 
while PLT 10^3 were higher in smokers than in no-smokers. 
Partecipants enrolled in the study were divided in 4 groups, according to their type of 
employment: farmer, craftsman, trader, student/unemployed. Scheffe Post-hoc pairwise 
comparisons were performed among the four employment groups and statistically significant 
differences were found for the following parameters: MON% (p=0.03), EOS% (p=0.03), 
BAS% (p=0.01) and AST (p=0.01) (additional file 1).  
For MON%, comparisons showed noticeable differences (i) between farmers and craftsmen 
with significantly lower values (p=0.03) in farmers and (ii) between students/unemployed 
and craftsmen, with significantly lower values (p= 0.03) in students/unemployed.  
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For EOS%, comparisons indicated that the difference was statistically significant between 
traders and craftsmen (p=0.03) with traders showing higher values. For BAS%, the 
comparisons indicated that the difference was statistically significant between traders and 
farmers (p=0.01) with traders showing higher values. 
For AST, comparisons revealed statistically significant differences (i) between traders and 
craftsmen (p=0.01) with traders showing higher values and (ii) between traders and farmers 
(p=0.01), still with traders showing higher values (p= 0.01). 
 
Comparison between reference values in Malian males and other countries  
Tables 2A and 2B show a summary, based on previously published data, of medians and 
unweighted lower and upper limits reference values (the lower limit defined as the 2.5
th
 
percentile and the upper limit as the 97.5
th
 percentile, according to United States National 
Consensus Committee on Laboratory Standards of normal ranges for laboratory tests [7]), 
stratified by race and ethnicity [5,6, 8-17]. Although most Malian normal ranges appeared to 
be close to the RIs reported for other race/ethnicities, some deviated significantly from the 
corresponding range in different populations. Figure 1 shows all African countries, for which, 
to our knowledge, reference ranges have been reported in the literature [5,6,8-16,18-25] .  
Moreover, considering that Italian RIs are representative of South Europe normal ranges, the 
comparison between the reference values for Italian [26] and Malians patients is illustrated in 
Table 3; figure 2 shows the comparison between the white cell differential count reference 
values for Italians and Malians. 
 
Discussion 
The International Federation of Clinical Chemistry recommends that each country should 
establish their own RIs for healthy subjects [1].  RIs play a pivotal role in clinical practice 
and the accuracy of the values used can reduce the risk of disease misdiagnosis. In fact, about 
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60–70% of all clinical decisions regarding a patient's diagnosis and treatment or hospital 
admission and discharge are made on the basis on laboratory test results [27].  
Haematological reference values have, so far, been determined for the Caucasian population 
[28,29] but not yet for all other countries. Hence, RIs for analysis of haematological 
parameters in routinary clinical practice in Africa are generated from Caucasian adult 
populations living in developed countries [30]. However, as a result of clinical trials and 
preventive interventions for HIV, tuberculosis and malaria, in the past two decades RIs have 
been established in several African countries, especially in southern, east and west Africa. 
Unfortunately the data reported so far is rather variable, due to discrepancies in the statistical 
methods used. In future, it would be desirable to have more homogeneous methods and 
therefore comparable data. 
More than a million migrants and refugees crossed into Europe in 2015 and 153,842 asylum 
seekers landed on the Italian coasts [31]. It is important to assess the state of health of all 
migrants and the correct identification of RIs relevant to different races and ethnicities, would  
allow clinicians and practitioners to manage laboratory tests and therapies more efficiently. 
Since haematological reference values have never been established for Malian people, the 
present study aimed to evaluate the RIs for haematological and biochemical parameters in 
healthy Malian male adult asylum seekers (ASs) housed in the largest Italian ASC. Many 
factors influence haematological values such as sex, age, ethnic origin, geographic location, 
climate, body mass index (BMI),  and genetic differences (5,6, 32-34]. 
In accordance with the internal procedure, each Asylum Seeker (AS) who accessed at IHCF 
for the first time completed a standardized questionnaire focused on socio-demographic data 
and was given  a physical examination, including the collection of vital signs and 
anthropometric data. The study group consisted exclusively of males, mainly due to the low 
percentage of women hosted at the ASC.  
Only migrants without any disease were included into the study. Most of them were in good 
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health status, which was expected, as many studies before have reported that ASs are 
generally young and healthy and only present minor health problems [35-39].  Hence, 
because of the selection process, the assessed RIs were not influenced by sex and previous or 
actual, acute or chronic diseases. On the other hand, anthropometric and social factors had 
only a partial impact on haematological and biochemical RIs. When we analyzed the results 
considering the BMI, we found that in people with abnormal BMI some of the platelet 
parameters (MPV, PCT and RDW)  deviated from RIs, probability  due to the fact that those 
factors have been linked with  an increased risk of microvascular blood flow resistance [40] 
and vascular mortality [41].  
Regarding chronologic age, we found an increased value of MCV and MCH with aging in 
Malians, in both white and black people, as already reported in literature [42,43]. In fact, it 
has been suggested that MCV increases gradually during early adulthood, levels off around 
middle adulthood
,
to rise again in old age. Thus, such fluctuations  might be associated with 
differences in red blood cell survival [42]. 
In agreement with other studies, we found higher level of PLT and EOS in younger Malians, 
when compared with older partecipants, for reasons not yet fully understood [44].  
Concerning the smoking-status, smokers seem to present higher level of PLT than no-
smokers, probably due to an indirect effect of nicotine causing a release of platelets in 
peripheral circulation [45]. Surprisingly, in our analysis Hb and HCT tended to be higher in 
no-smokers than in smokers, unlikely the literature data [46,47]. These observations need to 
be confirmed. 
Considering partecipants’ work activity, statistically significant differences were found 
between farmers, craftsmen, traders and students/unemployed only for white cell differential 
count (MON%, EOS%, BAS%) and AST. These differences (especially with regard to 
eosinophils) could reflect an occupational exposure to alternative types of allergens or 
pathogens, despite the fact that, at the time of blood sampling, the patients had no symptoms 
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or any sign of ongoing disease. 
When we compared the RIs of Malians with references of white Americans, African-
Americans and Europeans, we observed some interesting differences. In particular, we found 
a distribution of normal Malian (and Kenyan) values for EOS largely different from non-
Africa resident population. The high values of EOS observed in a portion of the Malian and 
Kenyan people, when assessed with European or American RIs, could lead the clinician to 
evaluate the patient as suffering from the condition of hypereosinophilia. However, 
considering the specific RIs for these populations, many “apparent” hypereosinophilic 
syndrome individuals fall within the normal ranges and their results can be considered a 
physiological finding. This evidence is confirmed by the observation that for up to 50% of the 
asymptomatic immigrants a cause for eosinophilia was never identified, despite exhaustive 
evaluation [48]. In clinical practice, the clinical evaluation of these patients prudentially 
required a critical approach. Given the epidemiology of parasitic diseases in sub-Saharan 
countries, in our opinion, a full examination on the possible causes of secondary 
hypereosinophilia is nevertheless recommended. Practitioners should be always aware of the 
possible impact of the use of incorrect RIs and its fallout on clinical and laboratory evaluation 
of subjects from different race/ethnicity. Another interesting observation was that the median 
value of MON tended to be higher in Malian than in European persons. Interestingly, studies 
showed that the mild relative monocytosis observed in West African patients may be 
indicative of an anti-malaria effect played by monocytes; in fact, these cells play a role in the 
quality of antimalarial response and may enhance the predisposition to a favourable clinical 
outcome [49]. Based on an adaptive-evolutionary point of view, it is possible that the greater 
RIs for monocytes in Malian population than in the Europeans can be somewhat linked to 
factors such as the one described above. 
According to the Clinical Laboratory Standards Institute (CLSI) Guideline recommendations, 
a minimum size of 120 observations from each category is needed [50] and although the 
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sample size of our study is considered sufficient to define RIs, our research suffers many 
limitations and further larger studies are needed. In particular, the absence of a female sample 
reduces the quality of the information collected and the use of standardized questionnaire 
focused on socio-demographic data and medical history may have represented a source of 
bias.  
However, despite its limitations, this paper represents the first systematic collection of 
biochemical and haematological data from Malian healthy persons. Unlike other similar 
studies, the patients’ state of health was not determined from the patient, but was defined in 
all patients by medical evaluation. 
 
Conclusion 
In conclusion, our data provide region-specific reference values which can be used to manage 
Malian patients (and populations with similar ethnic characteristics residents in neighboring 
areas) in and outside Africa. Taking into account the natural variations in the distributions of 
laboratory test results among racial/ethnic groups, this work will contribute to reduce disease 
misdiagnosis and to improve the quality of clinical care provided to migrants in the host 
country. 
 
What is already know on this topic 
 
Guidelines by the International Federation of Clinical Chemistry recommend that every 
country establish reference intervals (RIs) for health. The haematological reference values 
have, so far, been determined for the Caucasian population but not yet for all others 
countries. 
The RIS are very important for diagnostic orientation and treatment decision. 
 
What this study adds 
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The present study provides region-specific reference values which can be used to improve 
diagnosis and clinical care of Sub-Saharan Africans in and outside Africa,  although furher 
studies on adult Malian living in Mali are needed to confirm our observation. 
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Figure Legends 
Figure 1. African countries where haematological reference ranges have already been 
described (evidenced in black). 
 
Figure 2. Comparison between the white cell differential count reference values for Italian 
(representative for South European population) and Malians partecipants. Data are expressed 
as median and reference values (2.5
th
-97.5
th
 percentiles). Horizontal lines show the lower and 
upper limits of normal range for the population analyzed (in black Malians, in gray Italians) 
and the dot on each line represents the estimated median value.  
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Tab. 1 Clinical and biochemical parameters of the study population     
Test N° % Mean SD Median 2.5
th
 97.5
th
 
SBP* 118 94.4 124 11.2 120 106 140 
DBP** 118 94.4 77.2 9.1 80 60 90 
HR*** 116 92.8 75.9 12.6 73 58 100 
WBC (10^3/L) 125 100 7.1 1.8 7 4.6 10.1 
RBC (10^6/L) 125 100 5.2 0.4 5.2 4.6 6 
HB (gr/dl) 125 100 15 1.0 15.1 13.4 16.6 
HCT (%) 125 100 46.6 2.9 46.7 41.9 51 
MCV (fl) 125 100 88.6 5.9 89 78 98 
MCH (pg) 125 100 28.6 2.1 28.7 25.1 31.9 
MCHC (gr/dl) 121 96.8 32.3 0.9 32.3 31.1 33.9 
RDV (%) 121 96.8 14.2 1.3 14 12.6 16.5 
PLT (10^3/L) 125 100 219.6 46.3 222 152 297 
MPV (fl) 121 96.8 9.5 3.6 9.1 7.6 11.3 
PCT (%) 121 96.8 0.3 0.6 0.2 0.1 0.3 
PDW (fl) 121 96.8 16.5 2.4 16.1 15.5 17.6 
LYM (%) 125 100 51 9.3 52.2 34.9 63.2 
MON (%) 125 100 8.7 2.2 8.7 5.1 12.3 
NEU (%) 125 100 33.2 8.4 33.2 19.9 48.5 
EOS (%) 125 100 6.5 6.1 4.5 1.4 17.2 
BAS (%) 125 100 0.6 0.4 0.5 0.2 1.1 
BUN**** (g/dl) 95 76 24.4 4.8 24 16 32 
Glycemia (mg/dl) 123 98.4 91.9 11.8 90 78 111 
Creatinine (mg/dl) 122 97.6 0.9 0.1 0.9 0.7 1.2 
AST (UI/l) 123 98.4 23.3 6.9 22.0 15.0 35 
ALT (UI/l) 123 98.4 19.2 8.3 17.0 9.0 35 
*SBP Systolic Blood Pressure, **DBP Diastolic Blood Pressure, ***HR Hearth Rate,    
****BUN Blood Urea Nitrogen           
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Table 2 A. Comparison between reference values for Malian males and those from other countries      
  
Mali Mozambique 
(Tembe et 
al.)[8] 
Ghana (Koram et 
al.)[9] 
Kenya                  
(Kibaya et al.) 
[5] 
Tanzania 
(Saathoff et al.) 
[6] 
Botswana (Mine 
et al.) [10] 
Ethiopia 
(Yalew et al.) 
[11] 
CAR 
(Menard et al.) 
[12] 
RBC              
(x10^6/υL) 
5.2(4.6-6) 5.1(2.7-6.1) 4.8(3.8-5.9) 5.3(4.4-6-3) 5.2(4.4-6.2) 5.18(4.2-6.3) 5.01(3.53-6.93) 5.14(4.5-6.1) 
HB (gr/dl) 15.1(13.4-16.6) 14.1(12.3-16.4) 11.7(11.7-16.5) 9.9(8.3-11.3) 15.4(13.7-17.7) 15.3(11.9-17.1) 14.2(11.5-18) 14.9(12.3-17.3) 
HCT (%) 46.7(41.9-51) 42.8(25.2-50.4) 44.1(37.1-51.4) 47(40-50) 46.6(40.2-53.7) 43.3(36.1-49.3) 46.9(36.2-58.6) 45(29-52) 
MCV (fl) 89(78-98) 85.8(72.4-92.9) NA 88(71.4-98.2) 89.3(76.4-98.8) 84(73.8-95.6) 92(85-100)* NA 
MCH (pg) 28.7(25.1-31.9) NA NA NA NA 29.5(23.4-33.3) 29(26.6-33-3) NA 
PLT 
(x10^3/υL) 
222(152-297) 231(116-392) 209(97-356) 218(115-366) 224(147-356) 277.5(141-494) 264(128-432)* 225(124-378) 
WBC              
(x10^3/υL) 
7(4.6-10.1) 4.6(2.0-7.7) 5.6(3.4-8-8) 4.3(2.7-7.5) 4.4(2.8-7.9) 4.84(2.9-7.9) 5.1(3.2-8.8)* 5.05(2.09-8.3) 
NEU (%) 33.2(19.9-48.5) 52.5(34.4-70.8) 40.5(24.4-60.7) 42(20-70) 47.3(31.7-69.3) 52.5(29.4-73-4) 53(36-69)* NA 
LYM (%) 52.2(34.9-63.2) 39.1(15.5-57.1) 48.2(27.5-66.5) 45(20-60) 40.8(20.8-57.3) 8.42(15.8-56.7) 38(22-55)* NA 
MON (%) 8.7(5.1-12.3) NA NA 7(3-12) NA 7.9(3.2-15.9) NA NA 
EOS (%) 4.5(1.4-17.2) NA NA 4(1-20) NA 2(0.2-12.14) NA NA 
BAS (%) 0.5(0.2-1.1) NA NA 0(0-2) NA 0.4(0-1.5) NA NA 
Gly (mg/dl) 90(78-111) 79.2(55.8-102.7) NA 73.8(55- 100.9) 73(53 -94) NA NA NA 
BUN 
(mg/dl) 
24(16-32) 10.6(5-16.2) 12. 3(4.7-20.1) 7.8(4.2-12.8) 7.5(4.2 - 13.9) NA NA NA 
Creatinine 
(mg/dl) 
0.9(07-1.2) 0.91(0.65- 1.23) 1.19(0.92- 1.59) 0.87(0.7-1.19) 0.7(0.54-1.08) NA NA NA 
AST (UI/L) 22(15-35) 25.7(16.8-45.5) 31.3(18.7 - 65) 23.9(14.9-45.3) 22.8(14.2-48.1) NA NA NA 
ALT (UI/L) 17(9-35) 15.9(6.5-53.2) 24.3(11.6- 53.1) 22.3(10.8-53.9) 19(7.7-48.3) NA NA NA 
°Central Africa Republic,  * Values for female and males           
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Table 2 B. Comparison between reference values for Malian males and those from other countries      
  
Rwanda  
(Karita et al.) [13] 
Uganda, Masaka  
(Karita et al.) [13] 
Zambia 
(Karita et al.) 
[13] 
Togo                     
(Kueviakoe et al.) 
[14] 
South Africa 
(Lawrie et al.) 
[15] 
Zimbawe 
(Samaneka et al.) 
[16] 
African-
American 
(Lim et al.) 
[17] 
White  
 (Lim et al.) [17] 
RBC            
(x10^6/υL) 
5.16(4.25-6.16) 5.13(3.8-6.23) 
4.83(3.82-
5.77) 
5(3.3-6.4) NA(3.93-4.5) 5.5(3.9-5.9)  NA(3.9-4.7) NA(4.1-5.6) 
HB (gr/dl) 15.8(13.2-17.7) 14.9(11.7-17.2) 
14.6(12.9-
16.8) 
15.1(10-18.4) NA(13.4-17.4) 15.9(10.2-15.9) NA(12-16.4) NA(13.4-17.3) 
HCT (%) 45.6(39.4-51.7) 43.7(34.6-50.2) 
43.55(38.1-
49.4) 
42.8(28-54) NA(39-51) 48.5(33.9-48.7) NA(36.1-49.6) NA(38.7-50) 
MCV (fl) 89(78-99) 86(70-95) 91.5(75-104) 85(80-99) NA(83.1-101.6) 88.8(68.8-100.7) NA(74.1-99.1) NA(82.6-99.1) 
MCH (pg) NA NA NA 29.7(26-36) NA(27.8-34.8) 29.4(20.7-32.1) NA(24.2-34.2) NA(28.5-34.8) 
PLT 
(x10^3/υL) 
232(130-278) 192(54-351) 
227.5(137-
347) 
236(120-443) NA(171-388) 229(163.8-431) NA(134-349) NA(136-366) 
WBC             
(x10^3/υL) 
4.5(3-7.5) 5.3(3.1-9.6) 4.7(3.1-7.2) 41.(1.9-10.1) 3.92(10.4) 4.6(3.3-8.3) NA(3.4-10.6) NA(4.0-12.2) 
NEU (%) 43.5(23-62.5) 37.1(20.7-58.7) 
48.75(29.2-
67) 
1.6(0.5-5.4) NA(32-76) 43.3/27.1-62) NA(32.3-75.3) NA(43.2- 75.3) 
LYM (%) 42(26.4-58.6) 40.2(23.3-59.4) 
39.1(22.4-
59.4) 
2.1(1.1-4.3) NA(18-56) 43(28.4-59) NA(16.8-54.2) NA(16-43.5) 
MON (%) 8.9(5.4-14.8) 8.5(4.9-14.8) 7.4(4.2-12.1) 0.2(0.05-0.8) NA(4-12) 8.6(4.6-12.1) NA(3.4-12.0) NA(3.8-12.6) 
EOS (%) 3.2(0.9-16.6) 8.7(1.5-28.9) 2.9(0.8-16.7) 0.2(0-0.5) NA(0-8) 2.7(0.4-10-8) NA(0.6-9.6) NA(0.6-7.6) 
BAS (%) 0.8(0.4-3.2) 0.7(0.4-1.7) 0.3(0.1-0.6) NA NA(0-2) 0.4(0.1-1) NA(0-3.2) NA(0-2.7) 
Gly (mg/dl) NA NA NA NA NA 79.5(63.5-99) NA(69-220) NA(66-161) 
BUN 
(mg/dl) 
NA NA NA NA NA 9.8(3.9-15.4) NA(6-20) NA(6-21) 
Creatinine 
(mg/dl) 
0.83(0.46-1.26) 0.89(0.67-1.26 
0.96(0.66-
1.32) 
NA NA 0.9(0.5-1.1) NA(0.73-1.45) NA(0.70-1.27) 
AST (UI/L) 26(17-79) 28(17-58) 26(15-94) NA NA 28(12-40) NA NA 
ALT (UI/L) 22(9-54) 24(11-49) 25(12-62) NA NA 21(5-35) NA(11-64) NA(12-87) 
°Central Africa Republic,  * Values for female and males           
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Table 3.  
 
Table 3 Comparison between haematological reference values for Italian (representative for South European population) and Malian males 
  
Italian males Malian males 
Median 2.5
 th
 97.5
 th
 Median 2.5
 th
 97.5
 th
 
WBC (x10^3/uL) 6.03 4.19 9.35 7.0 4.6 10.1 
RBC (x10^6/uL) 5.22 4.71 5.82 5.2 4.6 6 
Hb (g/dL) 15.5 14.2 17.2 15.1 13.4 16.6 
HCT (%) 46 43.1 51.5 46.7 41.9 51 
MCV (fl) 88.6 81.8 95.3 89 78 98 
MCH (pg) 29.6 27.3 32.2 28.7 25.1 31.9 
MCHC (g/dl) 33.4 31.9 35.9 32.3 31.1 33.9 
RDV (%) 12.9 11.9 14.4 14 12.6 16.5 
PLT (x10^3/uL) 232 164 350 222.0 152 297 
MPV (fl) 10.9 9.5 12.3 9.1 7.6 11.3 
PCT (%) 0.3 0.2 0.4 0.2 0.1 0.3 
PDW (fl) 13.6 10.8 17.3 16.1 15.5 17.6 
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Additional file 1. Stratification of the study population by age, BMI, smoking and employment status 
 
Variable 
 
PParameter 
 
RBC               
(x10^6/υL) 
HB  
(gr/dl) 
HCT  
(%) 
MCV  
(fl) 
MCH  
(pg) 
MCHC 
(gr/dl) 
RDV  
(%) 
PLT 10^3 
(x10^3/υL) 
MPV  
(fl) 
PCT  
(%) 
PDW  
(fl) 
Smoker Mean 5.15 14.73 45.75 88.51 28.48 32.18 14.43 233.41 9.04 0.26 16.19 
  Ref.Range 4.98-5.32 14.23-15.23 44.37-47.13 86.17-90.85 27.64-29.31 31.79-32.56 13.85-15.01 211.7-255.13 8.48-9.60 0.13-0.38 15.96-16.42 
  Median  5.1 14.9 45.9 88 28.4 32.2 14.2 231 8.7 0.2 16.1 
  SD 0.4 1.19 3.25 5.52 1.97 0.9 1.37 51.23 1.31 0.6 0.54 
No-smoker Mean 5.28 15.13 46.87 88.58 28.6 32.27 14.12 215.06 9.68 0.27 16.54 
  Ref.Range 5.18-5.38 14.92-15.35 46.24-47.50 87.15-90.01 28.1-29.1 32.07-32.48 13.83-14.42 204.73-225.38 8.69-10.67 0.1-0.44 15.88-17.20 
  Median  5.2 15.1 46.8 89 28.8 32.3 14 214 9.15 0.2 16.1 
 
SD 0.42 0.91 2.69 6.06 2.13 0.85 1.23 43.93 4.12 0.7 2.74 
  p-value 0.14 0.05 0.05 0.95 0.78 0.59 0.24 0.05 0.39 0.68 0.48 
                          
Normal BMIs Mean 5.25 15.05 46.56 88.63 28.6 32.30 14.25 219.30 9.26 0.2 16.26 
 
Ref.Range 5.15-5.35 14.77-15-30 45.81-47.31 87.11-90.15 28.09-29.13 32.08-32.53 13.94-14.56 206.89-231.71 8.95-9.58 0.19-0.21 16.08-16.45 
 
Median  5.20 15.2 46.2 89.0 28.7 32.3 14.2 220.0 9.3 0.2 16.09 
  SD 0.40 1.05 3.03 6.11 2.11 0.92 1.23 49.82 1.24 0.04 0.72 
Abnormal 
BMIs Mean 5.26 14.82 46.51 87.90 28.28 32.05 14.28 214.57 11.18 0.55 17.62 
 
Ref.Range 5.03-5.50 14.3-15.34 45.34-47.68 85.2-90-63 27.24-29.32 31.60-32.49 13.53-15.04 191.44-237.69 6.30-16.07 0.30-1.41 14.37-20.86 
 
Median  5.3 14.8 45.8 87 28.5 31.5 14.8 201.0 9.18 0.2 16.32 
 
SD 0.44 0.86 2.12 5.16 1.96 0.78 1.34 43.73 8.71 1.53 5.78 
 
p-value 0.82 0.76 0.94 0.61 0.52 0.26 0.91 0.69 0.02 0.02 0.02 
                          
≤25 years Mean 5.29 14.96 46.42 87.4 28.15 32.21 14.27 228.6 9.78 0.31 16.45 
 
Ref.Range 5.18-5.40 14.67-15.24 45.61-47.23 85.7-89.10 27.57-28.74 31.95-32.47 13.88-14.65 215.08-242.12 8.46-11.09 0.08-0.53 15.58-17.32 
 
Median  5.3 15.1 46.3 88 28.2 32.2 14 229 9.1 0.2 16 
  SD 0.41 1.04 2.97 6.25 2.14 0.93 1.39 49.73 4.73 0.81 3.13 
≥26 years Mean 5.18 15.13 46.82 90.09 29.11 32.29 14.12 207.79 9.18 0.19 16.45 
 
Ref.Range 5.04-5.32 14.84-15.42 45.96-47.68 88.49-91.69 28.52-29.70 32.05-32.54 13.77-14.47 195.62-219.96 8.82-9.54 0.18-0.20 16.23-16.66 
 
Median  5.1 15.15 47 91 29.25 32.3 14 202 9.1 0.2 16.3 
 
SD 0.43 0.93 2.73 5.1 1.88 0.78 1.11 38.77 1.13 0.03 0.68 
  p-value 0.14 0.34 0.44 0.01 0.01 0.6 0.53 0.01 0.37 0.29 0.98 
                          
28 
 
Craftsman Mean 5.23 15.12 46.64 88.93 28.85 32.48 13.83 212.62 9.39 0.20 16.18 
 
Ref.Range 5.02-5.44 14.69-15.56 45.37-47.92 86.37-91.49 28.06-29.63 32.01-32.95 13.47-14.19 195.50-229.74 8.87-9.91 0.19-0.22 15.80-16.55 
 
Median  5.20 15.20 46.80 89.00 28.70 32.30 14.00 217.00 9.25 0.20 16.10 
  SD 0.48 1.00 2.91 5.81 1.78 1.04 0.80 38.93 1.15 0.04 0.83 
Farmer Mean 5.20 15.12 46.83 89.81 28.96 32.26 14.41 232.08 8.98 0.22 16.22 
 
Ref.Range 5.05-5.36 14.68-15.56 45.51-48.15 87.33-92.28 28.11-29.81 32.00-32.52 13.86-14.96 209.23-254.93 8.47-9.49 0.20-0.23 15.99-16.44 
 
Median  5.20 14.95 46.75 89.50 28.95 32.30 14.05 230.00 8.95 0.20 16.10 
  SD 0.40 1.13 3.38 6.35 2.18 0.68 1.41 58.54 1.31 0.04 0.58 
Student/ 
unemployed Mean 5.33 14.93 46.23 86.21 27.85 32.19 14.49 206.26 9.76 0.20 16.55 
 
Ref.Range 5.13-5.53 14.40-15.47 44.77-47.69 84.01-88.41 26.87-28.83 31.69-32.70 13.71-15.28 188.12-224.40 9.01-10.51 0.20-0.20 16.08-17.01 
 
Median  5.40 15.10 46.20 85.00 27.60 32.10 14.40 206.00 9.50 0.20 16.30 
  SD 0.36 0.96 2.60 3.92 1.74 0.84 1.32 32.34 1.24 0.00 0.77 
Trader Mean 5.22 14.91 46.35 88.68 28.51 32.13 14.07 217.68 10.30 0.43 17.11 
 
Ref.Range 5.04-5.40 14.53-15.29 45.31-47.40 85.90-91.45 27.48-29.54 31.73-32.53 13.57-14.58 198.96-236.40 7.28-13.32 0.15-0.95 15.11-19.10 
 
Median  5.10 15.10 47.00 91.00 29.00 32.30 14.10 221.00 8.95 0.20 16.15 
 
SD 0.43 0.90 2.48 6.54 2.43 0.92 1.17 44.17 6.99 1.22 4.63 
  p-value 0.76 0.75 0.86 0.20 0.27 0.47 0.17 0.18 0.55 0.47 0.43 
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Variable 
 
Parameter 
 
WBC 
(x10^3/L) 
L 
(%) 
M  
(%) 
N  
(%) 
E 
(%) 
B 
(%) 
BUN  
(mg/dl) 
       Gly  
     (mg/dl) 
Creatinine 
(mg/dl) 
      AST 
     (UI/L) 
       ALT 
      (UI/L) 
Smoker Mean 7,49 51,98 9 32,06 6,37 0,6 24,76 89,09 0,97 22,7 18,74 
  Ref.Range 6,65-8,33 49,09-54,86 7,99-10,02 29,52-34,60 4,69-8,05 0,51-0,68 22,63-26,90 84,46-93,72 0,92-1,02 19,98-25,43 15,61-21,87 
  Median  7,5 51,5 9,2 32,9 5,4 0,6 25 89 0,95 21 18 
  SD 1,98 6,8 2,38 5,99 3,95 0,2 4,56 10,92 0,11 6,43 7,38 
No-smoker Mean 7,01 50,67 8,6 33,61 6,56 0,56 24,2 92,79 0,94 23,52 19,39 
  Ref.Range 6,61-7,41 48,31-53,02 8,08-9,12 31,48-35,74 4,98-8,14 0,46-0,66 22,83-25,57 89,95-95,63 0,9-0,97 21,84-25,19 17,33-21,44 
  Median  6,8 52,6 8,65 33,3 3,9 0,5 24 90 0,93 20 17 
 
SD 1,69 10,03 2,2 9,06 6,72 0,42 4,97 11,96 0,15 7,03 8,66 
  p-value 0,19 0,5 0,38 0,37 0,88 0,6 0,61 0,13 0,2 0,57 0,7 
                          
Normal BMIs Mean 7.23 51.28 8.88 32.69 6.58 0.56 24.12 90.84 0.94 23.57 18.54 
 
Ref.Range 6.79-7.68 48.83-53.73 8.30-9.44 30.47-34.91 4.89-8.28 0.46-0.67 22.76-25.49 88.07-93.60 0.90-0.98 21.94-25.19 16.42-20.67 
 
Median  7.01 53.2 8.95 32.33 4 0.5 24 89.3 0.93 23.1 16.9 
  SD 1.78 9.84 2.29 8.91 6.79 0.41 4.81 19.96 0.15 6.43 8.43 
 
Abnormal 
BMIs Mean 6.82 51.98 8.13 33.86 5.54 0.47 26.18 95.57 0.98 23.76 22.61 
 
Ref.Range 5.85-7.98 47.67-53.73 7.00-9.26 29.92-37.79 3.55-7.53 0.36-0.59 22.38-29.98 88.07-102.74 0.92-1.04 18.84-28.67 18.40-26.83 
 
Median  6.7 50.3 7.2 33.0 .3 0.4 25.5 93 0.99 19.8 22.8 
 
SD 1.83 9.84 2.13 7.43 3.76 0.21 6.10 13.55 0.11 9.29 7.97 
 
p-value 0.35 0.76 0.18 0.58 0.49 0.33 0.14 0.1 0.27 0.91 0.03 
                          
≤25 years Mean 7,13 50,33 8,31 32,93 7,83 0,6 24,02 90,92 0,91 23,38 18,51 
 
Ref.Range 6.64-7.63 47.98-52.69 7.7-8.92 31-34.86 5.85-9.80 0.48-0.73 22.21-25.82 87.74-94.10 0.88-0.95 21.43-25.33 16.4-20.62 
 
Median  7 50,8 8,5 34 5,9 0,5 24 89 0,91 22 17 
  SD 1,82 8,66 2,24 7,09 7,26 0,46 5,46 11,61 0,12 7,1 7,7 
≥26 years Mean 7,13 51,86 9,22 33,62 4,78 0,52 24,71 93,09 0,98 23,22 20,16 
 
Ref.Range 6.59-7.67 48.67-55.05 8.54-9.89 30.5-36.74 3.65-5.91 0.44-0.59 23.3-26.12 89.29-96.89 0.93-1.03 21.12-25.32 17.28-23.05 
 
Median  6,9 53,85 9,1 31,65 3,6 0,5 24,5 91 0,98 22 18 
 
SD 1,72 10,16 2,15 9,94 3,6 0,23 4,12 11,97 0,16 6,62 9,08 
  p-value 0,98 0,36 0,02 0,65 <0.01 0,2 0,48 0,31 0,01 0,89 0,27 
                          
30 
 
Craftsman Mean 6,82 53,52 9,71 31,88 4,36 0,53 22,83 91,75 0,95 22,21 17,52 
 
Ref.Range 5.98-7.65 49.35-57.68 8.52-10.91 27.89-35.87 2.93-5.79 0.44-0.62 20.72-24.93 86.69-96.81 0.89-1.00 19.74-24.67 14.41-20.62 
 
Median  6,70 56,40 9,30 30,90 3,60 0,50 23,00 89,00 0,93 21,00 16,00 
  SD 1,90 9,47 2,72 9,07 3,26 0,20 4,20 11,28 0,13 5,61 7,06 
Farmer Mean 7,21 51,94 8,38 33,84 5,39 0,46 24,52 92,42 0,96 21,80 18,26 
 
Ref.Range 6.55-7.86 48.35-55.53 7.52-9.23 30.44-37.25 3.72-7.06 0.39-0.52 22.60-26.43 87.27-97.56 0.89-1.03 20.06-23.54 14.96-21.55 
 
Median  7,15 53,00 8,35 34,00 4,15 0,40 25,00 89,50 0,94 22,00 16,00 
  SD 1,69 9,19 2,19 8,72 4,28 0,16 4,36 13,19 0,18 4,38 8,31 
Student/ 
unemployed Mean 6,87 47,50 8,14 35,56 8,24 0,56 27,00 90,95 0,93 22,95 19,74 
 
Ref.Range 5.79-7.95 43.02-51.98 7.16-9.12 32.01-39.11 5.01-11.47 0.46-0.67 21.93-32.07 81.82-100.08 0.84-1.02 19.07-26.83 15.14-24.33 
 
Median  6,80 46,10 8,20 34,40 6,60 0,60 26,00 88,00 0,91 21,00 19,00 
  SD 1,93 7,98 1,75 6,33 5,76 0,18 7,48 16,28 0,16 6,92 8,19 
Trader Mean 7,30 48,54 9,14 33,37 8,28 0,75 23,80 91,70 0,96 27,17 22,47 
 
Ref.Range 6.58-8.03 44.21-52.87 8.45-9.83 29.68-37.06 4.39-12.17 0.48-1.03 21.95-25.65 88.17-95.23 0.91-1.01 23.14-31.19 18.26-26.67 
 
Median  7,10 50,20 9,00 32,90 5,40 0,50 24,00 91,50 0,98 25,00 21,00 
 
SD 1,70 10,21 1,62 8,71 9,18 0,66 3,87 8,18 0,12 9,32 9,74 
  p-value 0,67 0,07 0,03 0,52 0,03 0,01 0,08 0,97 0,92 0,01 0,11 
 
 
